88 related articles for article (PubMed ID: 19007913)
1. Inhibition of phosphodiesterase has an additive effect on estrogen's ability to inhibit collagen synthesis in vascular smooth muscle cells.
Dimopoulos GJ; Langner RO
Vascul Pharmacol; 2009; 50(1-2):78-82. PubMed ID: 19007913
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vascular smooth muscle cells with estradiol and beta-adrenergic agonists has an additive effect on cAMP levels, but no additive effect on inhibition of collagen synthesis.
Dimopoulos GJ; Langner RO
J Pharm Pharmacol; 2005 Aug; 57(8):1005-10. PubMed ID: 16102256
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.
Chen YM; Wu KD; Tsai TJ; Hsieh BS
J Mol Cell Cardiol; 1999 Apr; 31(4):773-83. PubMed ID: 10329205
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors.
Palmer D; Tsoi K; Maurice DH
Circ Res; 1998 May; 82(8):852-61. PubMed ID: 9576105
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
Rapp NS; Zenser TV; Mattammal MB; Davis BB
J Pharmacol Exp Ther; 1981 Nov; 219(2):442-6. PubMed ID: 6169824
[TBL] [Abstract][Full Text] [Related]
6. Colforsin or imidazolidione potentiates cAMP elevation caused by endothelin-1 in rat aorta.
Zhou HL; Fiscus RR
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):295-9. PubMed ID: 7801766
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle.
Halene TB; Siegel SJ
J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599
[TBL] [Abstract][Full Text] [Related]
8. Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Netherton SJ; Jimmo SL; Palmer D; Tilley DG; Dunkerley HA; Raymond DR; Russell JC; Absher PM; Sage EH; Vernon RB; Maurice DH
Diabetes; 2002 Apr; 51(4):1194-200. PubMed ID: 11916944
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
Liu Y; Dolence J; Ren J; Rao M; Sreejayan N
J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
[TBL] [Abstract][Full Text] [Related]
10. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
Kather H; Scheurer A
Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP inhibits increased collagen production by cyclically stretched smooth muscle cells.
Kollros PR; Bates SR; Mathews MB; Horwitz AL; Glagov S
Lab Invest; 1987 Apr; 56(4):410-7. PubMed ID: 3031368
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors.
Bertram JS; Bertram BB; Janik P
J Cell Biochem; 1982; 18(4):515-38. PubMed ID: 6282911
[No Abstract] [Full Text] [Related]
13. Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth.
Dubey RK; Mi Z; Gillespie DG; Jackson EK
Hypertension; 1996 Nov; 28(5):765-71. PubMed ID: 8901821
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells.
Cai Y; Miller CL; Nagel DJ; Jeon KI; Lim S; Gao P; Knight PA; Yan C
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):616-23. PubMed ID: 21148428
[TBL] [Abstract][Full Text] [Related]
15. [Depressive effect of tetrandrine on collagen synthesis in vascular smooth muscle cells].
Li QP; Lu ZA; Rao MR
Yao Xue Xue Bao; 2001 Jul; 36(7):481-4. PubMed ID: 12585075
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin inhibitors activate glycogen phosphorylase B to A conversion in C6 glioma cells.
Norman JA; Staehelin M
Mol Pharmacol; 1982 Sep; 22(2):395-402. PubMed ID: 6183569
[No Abstract] [Full Text] [Related]
17. Phosphodiesterase-linked inhibition of nonmicturition activity in the isolated bladder.
Gillespie JI
BJU Int; 2004 Jun; 93(9):1325-32. PubMed ID: 15180632
[TBL] [Abstract][Full Text] [Related]
18. Effects of estradiol metabolites on cAMP production and degradation.
Tofovic PS; Rosado BM; Dubey KR; Mi Z; Jackson EK
Prilozi; 2009 Jul; 30(1):5-24. PubMed ID: 19736528
[TBL] [Abstract][Full Text] [Related]
19. Intravenously administered phosphodiesterase 4 inhibitors dilate retinal blood vessels in rats.
Miwa T; Mori A; Nakahara T; Ishii K
Eur J Pharmacol; 2009 Jan; 602(1):112-6. PubMed ID: 19027003
[TBL] [Abstract][Full Text] [Related]
20. [Effect of frequency of cyclic tensile strain on extracellular matrix of rat vascular smooth muscle cells in vitro].
Qu M; Liu B; Jiang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):826-30. PubMed ID: 18788289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
